As Riyadh confirms another case, local media are reporting a family cluster in the area.
In an ongoing trickle of MERS-CoV cases, especially from the Riyadh area, Saudi Arabia's health ministry today reported another infection. The latest case involves a 38-year-old Saudi man, and though he is from Riyadh, it's not clear whether his illness is part of recent transmission occurring in the city's hospitals or is from the community.
Saudia Arabia's case count reaches 1,063, while South Korea gives its health minister the boot over handling of the outbreak there.
Saudi Arabia's health ministry today announced two new MERS-CoV cases, both of them from Riyadh, an area that over the past several weeks has experienced a spate of hospital-linked cases.
Saudi Arabia reported another new MERS-CoV case in Riyadh today, while the World Health Organization (WHO) supplied details on eight other recent cases, including two possible chains of transmission involving at least five of the patients.
South Korea's government considers the hospital-linked outbreak over, as researchers reported on early vaccine and antibody findings.
Saudi Arabia's Ministry of Health (MOH) reported a new MERS-CoV case over the weekend and a death in a previously reported patient, both in Riyadh.
The new case involves a 30-year-old Saudi man who is hospitalized in stable condition, the MOH reported on Jul 25. He is not a healthcare worker but had contact with a MERS-CoV (Middle East respiratory syndrome coronavirus) patient in either a community or hospital setting, the MOH said.
As Saudi Arabia's Minister of Health (MOH) today confirmed a new MERS-CoV case—the sixth in 4 days—a study found higher viral loads to be associated with more severe disease.
Middle East respiratory syndrome coronavirus (MERS-CoV) has sickened four more people in Saudi Arabia in the past 2 days, one of them fatally, according to reports from the country's Ministry of Health (MOH).
Saudi Arabia's Ministry of Health (MOH) yesterday announced a new MERS-CoV case after going 4 days without one, and a study in macaques identified two drugs that might be candidate for human trials.
